Why the study?
Chronic kidney disease is a major global public health challenge due to its substantial incidence, prevalence, and severe impact on quality of life.
This study aims to describe the global and regional burden of chronic kidney disease and its correlation with sociodemographic and healthcare access indices.
Informs targeted CKD prevention strategies in underserved regions; extends global burden data for policy and trial design.
Chronic Kidney Disease (CKD) is a global public health problem due to its notable incidence, prevalence and serious effects on the quality of life of patients. This disease, characterized by a progressive and irreversible loss of kidney function, presents a significant challenge. This study aims to: 1) describe the burden of CKD in Latin American countries, and 2) analyze the correlation between years of healthy life lost (YLL) and sociodemographic indices (ISD) and access and quality of care. health (ACS). This analysis is based on data from the Global Burden of Disease (GBD) 2024 Study, a global collaboration that collects health data from various sources, including hospital records, surveys, and mortality data. The Scopus and Web of Science databases were consulted to review the existing literature on CKD and its global impact.
No takes yet. Share an insight, caveat, or question.
Balla et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: